GLPHubglpresearchhub.com
Read-only archive. GLP Research Hub is a static community record — nothing here is for sale, no account is needed, and no vote you cast is counted. Why?
85
c/glp1eu·posted 6 months ago by u/viktor_nkemelu

[Question] reimbursement — what am I missing here

Question

reimbursement — what am I missing here — that is what I am asking, and I have already read the wiki twice.

On cross-border prescriptions, since the assumption behind half these threads is wrong.

There are EU rules on the recognition of prescriptions issued in another member state, and they are conditional: the prescription has to meet requirements about its form and content, certain categories are excluded, and pharmacies retain discretion in practice.

The result is that "my prescription will be accepted anywhere in the EU" is not a safe assumption, and members here have discovered it at a counter in another country. If it matters for a trip, check before you travel with the pharmacy and with somebody qualified where you are. Nothing on this board is advice about that, and the rules are national in their application whatever the framework says.

Marketing authorisation is granted centrally for these products; reimbursement, pricing and prescribing criteria are national competences. Those are decided by different bodies with different processes.

Cross-border prescription recognition exists under EU rules but is conditional and narrower than commonly assumed, with requirements about the prescription’s form and content.

I will update this if the picture changes rather than quietly leaving it up.

88 up / 3 down96% upvoted11 commentsid zc6zky2 Jan 2026

11 comments

11 in this archive, depth 3

best — the order this archive was captured in

u/ignacio_vanhecke11 points·6 months ago

Pack sizes and presentations differ between member states, so a headline price is not comparable until it is normalised to a common quantity.

replysharereportpermalink
u/viktor_nkemeluOP7 points·6 months ago

Apotheke pricing and pharmacy pricing elsewhere are different systems

replysharereportpermalink
u/renal_outcomes_rnephro-curious-35 points·6 months ago

Nothing here is medical or legal advice, and eligibility questions have national answers that a pharmacist where you live can give you in minutes.

replysharereportpermalink
u/marit_mwangi11 points·6 months ago

Are you comparing the same presentation, or different pack sizes?

replysharereportpermalink
u/aa_analysis_andy5 points·6 months ago

What pack size is that price for?

replysharereportpermalink
u/rania_marchand7 points·6 months ago

Agreed that pharmacy margin regulation explains a lot of the price differences people find mysterious.

replysharereportpermalink
u/diego_iyer3 points·6 months ago

Agreed — authorisation is European, reimbursement is national, and almost every confused thread here misses that split.

replysharereportpermalink
u/viktor_nkemeluOP1 point·6 months ago

A supply notice in one member state made the front page here and had no effect at all where I am.

replysharereportpermalink
u/zeynep_weiss3 points·6 months ago

Yes. Pack sizes differ enough that per-month price comparisons across borders need to be normalised before they mean anything.

replysharereportpermalink
u/santiago_rasmussen1 point·6 months ago

pack sizes differ, so per-month comparisons need care

replysharereportpermalink
u/noor_ivaturi1 point·6 months ago

Same. Naming the country in the first line would fix most of the bad advice on this board.

replysharereportpermalink
About c/glp1eu

European access, country by country: prescription routes, reimbursement reality, pharmacy stock, EMA notices and the fact that "EU rules" is usually a national question wearing a European hat.

32kmembers
62submissions
Apr 2024created
submissions / month, last year
Sponsored

Sigma-Aldrich Standards

Certified reference materials for peptide identity and purity work.

sigmaaldrich.com
c/glp1eu rules
  1. Tag your country in the title. Bare "EU" questions get a template reply.
  2. Pricing posts need the date and the currency.
  3. EMA and national agency claims need a citation.
  4. Independent community. Nobody here sells anything, and anyone who tries is banned.
  5. Not medical advice. Describe what you did; never prescribe to a stranger.
  6. Claims need evidence. Batch numbers, dated screenshots, independent test reports, or a citation.
  7. No referral links, discount codes or affiliate URLs. Permanent ban, no appeal.
  8. No contact handles, wallet addresses or tracking numbers — they identify people.
  9. Be recognisably decent. Disagree hard, insult nobody.
Moderators
Volunteers. Unpaid, unaffiliated, and reachable through modmail only.
Before you read on

Several compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.